Publications by authors named "Jan D Bos"

Claim this Profile
H
House dust mite allergens Der f and Der p induce IL-31 production by blood-derived T cells from atopic dermatitis patients.
Krisztina Szegedi, Amanda van Lier, Pieter C Res, Saskia Chielie, Jan D Bos

Exp Dermatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Evelien Roekevisch, Mandy Elvira Schram, Mariska Maria Geertruida Leeflang, Marijke Willemijn Dorothée Brouwer, Louise Anna Andrea Gerbens, Jan Dositheus Bos

J Allergy Clin Immunol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study.
Maaike J Visser, Maarten M Verberk, Linda E Campbell, W H Irwin McLean, Florentine Calkoen, Jan D Bos

Contact Dermatitis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study.
Maaike J Visser, Maarten M Verberk, Frank J H van Dijk, Jan G Bakker, Jan D Bos

Contact Dermatitis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo.
Marije W Kroon, Charlotte Vrijman, Charlotte Chandeck, Bas S Wind, Albert Wolkerstorfer, Jan D Bos

Horm Res Paediatr· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin.
Marjan de Groot, Daisy I Picavet, Arno W R van Kuijk, Paul P Tak, Jan D Bos

Dermatology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells.
Angelic M G van der Aar, Daisy I Picavet, Femke J Muller, Leonie de Boer, Toni M M van Capel, Jan D Bos

J Invest Dermatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Marije W Kroon, Bas S Wind, Arne A Meesters, Albert Wolkerstorfer, J P Wietze van der Veen, Jan D Bos

J Dermatolog Treat· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.
Maria C Lebre, Christina L Jonckheere, Maarten C Kraan, Arno W R van Kuijk, Jan D Bos

Arthritis Res Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin.
Krisztina Szegedi, Andreas E Kremer, Sanja Kezic, Marcel B M Teunissen, Jan D Bos

Exp Dermatol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of fibrosis after nonablative and ablative fractional laser therapy.
Bas S Wind, Arne A Meesters, Marije W Kroon, Johan F Beek, J P Wietze van der Veen, Jan D Bos

Dermatol Surg· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot study.
Arne A Meesters, Bas S Wind, Marije W Kroon, Albert Wolkerstorfer, J P Wietze van der Veen, Jan D Bos

J Am Acad Dermatol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and refinement of the Millennium Criteria for atopic dermatitis.
Mandy E Schram, Mariska M G Leeflang, Jan Paul S DEN Ottolander, Phyllis I Spuls, Jan D Bos

J Dermatol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
Esther P M Tjin, Debby Konijnenberg, Gabrielle Krebbers, Henk Mallo, Jan W Drijfhout, Jan D Bos

Clin Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Mandy Elvira Schram, Evelien Roekevisch, Mariska Maria Geertruida Leeflang, Jan Dositheus Bos, Jochen Schmitt

J Allergy Clin Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
Jasper G van den Boorn, Daisy I Picavet, Paul F van Swieten, Henk A van Veen, Debby Konijnenberg, Jan D Bos

J Invest Dermatol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study on tertiary teledermatology: feasibility and acceptance of telecommunication among dermatologists.
Job P van der Heijden, Nicolet F de Keizer, Frans P Voorbraak, Leonard Witkamp, Jan D Bos

J Telemed Telecare· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
Marije W Kroon, Bas S Wind, Johan F Beek, J P Wietze van der Veen, Ludmila Nieuweboer-Krobotová, Jan D Bos

J Am Acad Dermatol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations.
Ivone Jakasa, Ellen S Koster, F Calkoen, W H Irwin McLean, Linda E Campbell, Jan D Bos

J Invest Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept: an overview of dermatologic adverse events.
Lidian L A Lecluse, Emmilia A Dowlatshahi, C E Jacqueline M Limpens, Menno A de Rie, Jan D Bos

Arch Dermatol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.
Pieter C M Res, Gamze Piskin, Onno J de Boer, Chris M van der Loos, Peter Teeling, Jan D Bos

PLoS One· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
Marc R Kok, Koen Vos, Jan D Bos, Paul-Peter Tak

J Clin Rheumatol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.
Bas S Wind, Marije W Kroon, Arne A Meesters, Johan F Beek, J P Wietze van der Veen, Jan D Bos

Lasers Surg Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment.
Marjan de Groot, Marcel B M Teunissen, Daisy I Picavet, Menno A de Rie, Jan D Bos

Exp Dermatol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
Jasper G van den Boorn, Debby Konijnenberg, Esther P M Tjin, Daisy I Picavet, Nico J Meeuwenoord, Jan D Bos

PLoS One· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis